{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:22:39Z","timestamp":1789748559639,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013116","name":"MERZ Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013116","name":"MERZ Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013116","name":"MERZ pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.parkreldis.2017.10.009","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T17:46:14Z","timestamp":1508435174000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Incobotulinum toxin A in Parkinson's disease with foot dystonia: A\u00a0double blind randomized trial"],"prefix":"10.1016","volume":"46","author":[{"given":"Isabelle","family":"Rieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Degos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Castelnovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Vial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Simonetta-Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Sangla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Fluch\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Guehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Burbaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Geny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Gayraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Ory-Magne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Bouhour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Llinares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Derost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Durif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2017.10.009_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.870100317","article-title":"\u201cOff\u201d painful dystonia in Parkinson's disease treated with botulinum toxin","volume":"10","author":"Pacchetti","year":"1995","journal-title":"Mov. Disord."},{"issue":"Suppl 7","key":"10.1016\/j.parkreldis.2017.10.009_bib2","first-page":"7","article-title":"Dystonia in Parkinson's disease","volume":"253","author":"Tolosa","year":"2006","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.parkreldis.2017.10.009_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000117409","article-title":"Treatment of dystonia occurring in parkinsonian syndromes by botulinum toxin","volume":"37","author":"Limousin","year":"1997","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.parkreldis.2017.10.009_bib4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11910-014-0511-3","article-title":"An update on the use of botulinum toxin therapy in Parkinson's disease","volume":"15","author":"Mills","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.parkreldis.2017.10.009_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2340\/16501977-2094","article-title":"Botulinum toxin for foot dystonia in patients with Parkinson's disease having deep brain stimulation: a case series and a pilot study","volume":"48","author":"AD1","year":"2016","journal-title":"J.\u00a0Rehabil. Med."},{"key":"10.1016\/j.parkreldis.2017.10.009_bib6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2017.10.009_bib7","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.42.6.1142","article-title":"What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study","volume":"42","author":"Hughes","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2017.10.009_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2017.10.009_bib9","series-title":"Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.parkreldis.2017.10.009_bib10","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry"},{"key":"10.1016\/j.parkreldis.2017.10.009_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/WNL.35.1.73","article-title":"Validity and reliability of a rating scale for the primary torsion dystonias","volume":"35","author":"Burke","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2017.10.009_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0304-3959(76)90113-5","article-title":"Graphic representation of pain (EVA)","volume":"2","author":"Scott","year":"1976","journal-title":"Pain"},{"key":"10.1016\/j.parkreldis.2017.10.009_bib13","first-page":"10","article-title":"Fitzpatrick R.PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures","volume":"245","author":"Peto","year":"1998","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.parkreldis.2017.10.009_bib14","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.parkreldis.2017.10.009_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2012.01.019","article-title":"Botulinum toxins in the treatment of primary focal dystonias","volume":"316","author":"Truong","year":"2012","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2017.10.009_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxicon.2012.12.004","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders","volume":"67","author":"Hallett","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.parkreldis.2017.10.009_bib17","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1080\/01421590701568262","article-title":"Botulinum toxin treatment of axial and cervical dystonia","volume":"29","author":"Benecke","year":"2007","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.parkreldis.2017.10.009_bib18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.20403","article-title":"Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study","volume":"20","author":"Truong","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2017.10.009_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2011.05.041","article-title":"U.S. XEOMIN Cervical Dystonia Study Group. Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN\u00ae, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia","volume":"308","author":"CL1","year":"2011","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2017.10.009_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/toxins8030065","article-title":"Conversion ratio between Botox\u00ae, Dysport\u00ae, and Xeomin\u00ae in clinical practice","volume":"8","author":"Scaglione","year":"2016","journal-title":"Toxins"},{"issue":"13","key":"10.1016\/j.parkreldis.2017.10.009_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2377-13-118","article-title":"OnabotulinumtoxinA muscle injection patterns in adult spasticity: a systematic literature review","volume":"8","author":"Nalysnyk","year":"2013","journal-title":"BMC Neurol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017303802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017303802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T11:03:39Z","timestamp":1589799819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802017303802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":21,"alternative-id":["S1353802017303802"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.10.009","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incobotulinum toxin A in Parkinson's disease with foot dystonia: A\u00a0double blind randomized trial","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}